Tarsadia Capital, LLC Aerie Pharmaceuticals Inc Transaction History

Tarsadia Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$9.12 - $14.49 $182,399 - $289,800	-20,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $1.46 Million - $2.02 Million	-140,000 Reduced 87.5%	20,000 $235,000
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $1.05 Million - $1.42 Million	-87,884 Reduced 35.45%	160,000 $2.36 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $2.93 Million - $6.33 Million	247,884 New	247,884 $3.35 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Tarsadia Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Tarsadia Capital, LLC with notifications on news.